Pilot Award Recipient: Ruth Kanthula, MD, MPH
Antiretroviral therapy (ART) allows HIV to be managed as a chronic condition.
Pilot Awards Recipients
The DC CFAR has funded a wide variety of research, including basic, clinical, epidemiologic, social behavioral and prevention HIV/AIDS science.
View the archive to learn more about awards given in 2017 or earlier.
Pilot Award Recipient: Ana María del Río-González, PhD, MA
Along with other transgender women (i.e., those assigned a male sex at birth, but who identify as female) of color, Latina transgender women (LTW) in Washington DC are heavily impacted by HIV.
Pilot Award Recipient: Conrad Russell Cruz, MD, PhD
Although HIV infection can be controlled by daily lifelong adherence to expensive antiretroviral therapies it cannot presently be cured.
Pilot Award Recipient: Nickie Niforatos Andescavage, MD
Pregnancies complicated by HIV have significantly higher risk of fetal complications,
Pilot Award Recipient: Nicole Angotti, PhD
As anti-retroviral treatment (ART) continues to help people living with HIV (PLWH) live longer, more and more PLWH will be growing older in the years ahead.
Pilot Award Recipient: Namita Kumari, PhD
The current antiretroviral drugs can manage HIV/AIDS but they do not eradicate the virus, making life long use of ART mandatory.
Pilot Award Recipient: Rachel Robinson, PhD
Stigma, poverty, and biology put men who have sex with men (MSM) at great risk for HIV globally.
Pilot Award Recipient: Carlos E. Rodriguez-Diaz, PhD
Latinxs are at disproportionate risk for HIV infection and, within this group, gay, bisexual, and other men who have sex with men (GBMSM) are showing an alarming increase in HIV incidence.
Pilot Award Recipient: Xionghao Lin, PhD
Human immunodeficiency virus-1 (HIV-1) remains a severe burden worldwide.
Pilot Award Recipient: Tamara Taggart, PhD
There is a daily pill called PrEP that can be taken by HIV negative people to prevent them from becoming HIV positive.